Login
Global company acquires Southern Cross Pharma
Maddocks has advised Lupin Limited and its wholly owned subsidiary Generic Health on the acquisition of Melbourne-headquartered Southern Cross Pharma.
Emma Musgrave
Firms: Maddocks (Lupin Limited); Rankin Business Lawyers (Southern Cross Pharma).
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: Lupin Limited and its wholly owned subsidiary Generic Health have acquired Southern Cross Pharma.
Value: Undisclosed.
Area: M&A.
Key players: The Maddocks corporate team advising on the acquisition was led by partner Damien Wurzel and senior associate Steven Tang and assisted by associate Jack Coventry and lawyer Cassandra Charlaftis.
The corporate team was supported by partner Lindy Richardson and senior associate Christopher Charalambous from the firm’s employment, safety and people team.
Deal significance: Lupin Limited is a Mumbai-headquartered listed pharmaceutical company, while Southern Cross Pharma is a Melbourne firm engaged in developing, registering, and distributing generic pharmaceuticals products.
“The strategic acquisition sees Generic Health gain access to Southern Cross Pharma’s portfolio of more than 60 currently registered products developed over the past 20 years,” a statement from Maddocks said.
